Arnott, C., Li, J., Cannon, C. P., de Zeeuw, D., Neuen, B. L., Heerspink, H. J. L., Charytan, D. M., Agarwal, A., Huffman, M. D., Figtree, G. A., Bakris, G., Chang, T. I., Feng, K., Rosenthal, N., Zinman, B., Jardine, M. J., Perkovic, V., Neal, B., & Mahaffey, K. W. (2021). the effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial. Diabetes, obesity & metabolism, 23(7), 1652–1659. http://access.bl.uk/ark:/81055/vdc_100132667038.0x000019